High rates of sustained virologic response at week @ were observed among patients with HCV subtypes @a and @b ( @ % and @ % , respectively ) and those with CC and non-CC IL@B genotypes ( @ % and @ % , respectively ) , as well as among patients who received ribavirin and those who did not ( @ % and @ % , respectively ) .